Heterogeneity of Treatment Response to Citalopram for Alzheimer Disease Patients with Aggression or Agitation: The CitAD Randomized Clinical Trial

OBJECTIVE: Pharmacological treatments for agitation and aggression in Alzheimer disease patients have shown limited efficacy. We assessed the heterogeneity of response to citalopram in order to identify individuals who may be helped or harmed. METHODS: In this double-blinded, parallel-group multicen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Psychiatry
Autors principals: Schneider, Lon S., Frangakis, Constantine, Drye, Lea T, Devanand, D.P., Marano, Christopher M., Mintzer, Jacob, Mulsant, Benoit H., Munro, Cynthia A., Newell, Jeffery A., Pawluczyk, Sonia, Pelton, Gregory, Pollock, Bruce G, Porsteinsson, Anton P., Rabins, Peter V., Rein, Lisa, Rosenberg, Paul B., Shade, David, Weintraub, Daniel, Yesavage, Jerome, Lyketsos, Constantine G.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419726/
https://ncbi.nlm.nih.gov/pubmed/26771737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2015.15050648
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars